Odyssey Thera compounding profiling service

Click2Contact

Using cutting-edge Protein-fragment Complementation Assay technology from Odyssey Thera, Lonza is able to offer profiling services that can shape and influence critical decisions about drug candidates.

This unique cell-wide analysis platform broadly addresses target classes, signalling pathways and cellular processes. Classify drugs by comparison to an extensive compound database defining MOA and predicting safety threats.

It features: analysis of drug activity for any target class or pathway across cellular systems; high-content/high-throughput data capture and analysis; in-depth data interpretation including comparison to an extensive database of known drugs and toxicants; improved decision making throughout the development process.

Suitable applications include: target validation, HTS, SAR testing, toxicity and drug safety screens and compound selectivity testing.